References
  1. Chen, E., Ghannoum, M., & Elewski, B. E. (2021). Treatment‐resistant tinea corporis, a potential public health issue. British Journal of Dermatology, 184(1), 164-165.
  2. Saunte DM., Pereiro‐Ferreirós M, Rodríguez‐Cerdeira C, et al. Emerging antifungal treatment failure of dermatophytosis in Europe: take care or it may become endemic. Journal of the European Academy of Dermatology and Venereology. 2021;35(7):1582-1586. doi:10.1111/jdv.17241
  3. Usman, B., Rehman, A., Naz, I., & Anees, M. (2021). Prevalence and antifungal drug resistance of dermatophytes in the clinical samples from Pakistan. Acta Microbiologica et Immunologica Hungarica, 202101461
  4. Ismail, F., Ghani, A., & Akbar, S. (2021). Emergence of Antifungal Azole Resistance in the Fungal Strains of Tinea corporis, Tinea capitis, Tinea cruris and Tinea pedis from the Locality of Southern Punjab, Pakistan. RADS Journal of Biological Research & Applied Sciences, 12(1), 24-38.
  5. Singh, A., Masih, A., Khurana, A., et al., 2018. High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene. Mycoses 61, 477–484.
  6. Rudramurthy, S.M., Shankarnarayan, S.A., Dogra, S., et al., 2018. Mutation in the squalene epoxidase gene of Trichophyton interdigitale and Trichophyton rubrum associated with Allylamine resistance. Antimicrob. Agents Chemother. 62, e02522–e2617. https://doi.org/10.1128/AAC.02522-17
  7. Sardana K, Kaur R, Arora P, Goyal R, Ghunawat S. Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre?. Indian Dermatol Online J. 2018;9(2):90-95. doi:10.4103/idoj.IDOJ_137_1
8. Jabet A, Brun S, Normand AC, Imbert S, Akhoundi M, Dannaoui E, et al. Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France. Emerg Infect Dis. 2022 Jan;28(1):229–33.
Arun, A. B., Hasan, M. M., Rackimuthu, S., Ullah, I., Mir, T., & Saha, A. (2021). Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (covid-19) pandemic. Infection Control & Hospital Epidemiology , 1–2. https://doi.org/10.1017/ice.2021.426